April 5, 2016 -The International Society for Cellular Therapy (ISCT), theglobal society of clinicians, researchers, regulators, technologists, and industry partners dedicated to the translation of cellular therapy into safe and effective therapies to improve patients’ lives, today announces the signing of amemorandum of understanding (MOU) with the Alliance for Regenerative Medicine (ARM), the international organization representing the gene and cellular therapies and the regenerative medicine sector.
The agreement has been signed by Massimo Dominici, M.D., ISCT President, and Morrie Ruffin, ARM Managing Director. ISCT will become an honorary member of ARM, and vice versa. This agreement will extend collaborations between the two international organizations. Since ARM’s establishment in 2009, both organizations have collaborated on a series of projects, including authoring white papers. ARM and ISCT members have held leadership roles in both organizations.